Wolverine Peptide Therapy (BPC-157 & TB-500)

The Wolverine blend, combining BPC-157 and TB-500, is used to accelerate healing, reduce inflammation, and support tissue repair after injury, surgery, or physical strain.

The Wolverine blend of BPC-157 and TB-500 offers the following potential benefits:

Results often appear in 1-4 weeks, with full benefits typically seen at 4-8 weeks

Safety and Side Effects

When used under medical supervision, the Wolverine blend is generally well-tolerated with a strong safety profile in published studies.
Possible side effects include:
- injection-site reactions,
- headache,
- nausea,
- fatigue — typically mild and resolving quickly.

The Scientific Foundation of the Wolverine Peptide Blend : Preclinical research and early human clinical trials emphasize the significant therapeutic potential of the BPC-157 and TB-500 combination.
Comprehensive systematic reviews indicate that BPC-157 effectively supports structural restoration and functional improvement for tendon tears and complex musculoskeletal damage.
Meanwhile, TB-500 research focuses on its powerful role in dermal and internal wound repair, with data confirming its ability to drive regeneration through cell migration and new blood vessel formation.
Furthermore, extensive clinical observations point to accelerated post-operative healing, rapid recovery from sports injuries, and lasting relief for chronic conditions like plantar fasciitis and persistent tendinopathy.

How Does Wolverine Work?

The Wolverine blend combines BPC-157 and TB-500 to enhance the body’s healing and recovery processes through complementary mechanisms.

BPC-157 is a synthetic peptide derived from a protein found in gastric juice. Studies show it promotes angiogenesis (new blood vessel growth), stimulates tissue regeneration in muscle, tendon, ligament, and bone, reduces inflammation, and supports gut health — increasing delivery of growth factors to injury sites and reducing inflammatory cytokines.

TB-500 is the active portion of Thymosin Beta-4, a peptide produced in the thymus gland. Research shows it promotes cell migration to injury sites, activates cells important for healing, and reduces inflammation and scarring — aggregating the body’s repair cells precisely where they’re needed.

Together, BPC-157 and TB-500 work synergistically — increasing blood flow to injury sites, aggregating and activating repair cells, and reducing inflammation and scarring. The combination stimulates the body’s own healing mechanisms in a way that conventional anti-inflammatory medications do not.

Contraindications include pregnancy or breastfeeding, active or suspected cancer, and severe liver or kidney disease.

All peptides are sourced from licensed compounding pharmacies.

Disclaimer: The Wolverine peptide blend is not an FDA-approved medication.

References

Typical treatment protocols:

Cycles of 5 days per week for 1-3 months, followed by 2-4 weeks off.

Wolverine Peptide Therapy (BPC-157 & TB-500)

The Wolverine blend, combining BPC-157 and TB-500, is used to accelerate healing, reduce inflammation, and support tissue repair after injury, surgery, or physical strain.

The Wolverine blend of BPC-157 and TB-500 offers the following potential benefits:

Accelerated healing of tendons, ligaments, and muscle

Improved recovery after surgery or injury

Reduced inflammation and joint pain

Improved mobility and flexibility

Support for gut health

Improved resilience with physical stress and strain

Results often appear in 1-4 weeks, with full benefits typically seen at 4-8 weeks

Safety and Side Effects

When used under medical supervision, the Wolverine blend is generally well-tolerated with a strong safety profile in published studies.
Possible side effects include:
- injection-site reactions,
- headache,
- nausea,
- fatigue — typically mild and resolving quickly.

How Does Wolverine Work?

The Wolverine blend combines BPC-157 and TB-500 to enhance the body’s healing and recovery processes through complementary mechanisms.

BPC-157 (Body Protection Compound-157):

TB-500 (Thymosin Beta-4 Acetate):

TB-500 is the active portion of Thymosin Beta-4, a peptide produced in the thymus gland. Research shows it promotes cell migration to injury sites, activates cells important for healing, and reduces inflammation and scarring — aggregating the body’s repair cells precisely where they’re needed.

Wolverine Blend (BPC-157 & TB-500):

Contraindications include pregnancy or breastfeeding, active or suspected cancer, and severe liver or kidney disease.

All peptides are sourced from licensed compounding pharmacies.

Disclaimer: The Wolverine peptide blend is not an FDA-approved medication.

References

1. Vasireddi, N., Hahamyan, H., et al. "Emerging use of BPC-157 in orthopaedic sports medicine: A systematic review." HSS Journal 2025;21(2).

2. Pickart L, Vasquez-Soltero JM, et al. "Regeneration or risk? A narrative review of BPC-157 for musculoskeletal healing." Current Reviews in Musculoskeletal Medicine 2025;18(12):611–619.

3. Seiwerth, S., Milavic, M., et al. "Stable gastric pentadecapeptide BPC 157 and wound healing." Frontiers in Pharmacology 2021;12.

4. Malinda, K. M., Wang, J., et al. "Thymosin beta-4 accelerates wound healing." Journal of Investigative Dermatology 1999;113(3):364–368.

5. Xing, Y., Ye, Y., et al. "Progress on the function and application of Thymosin β4." Frontiers in Endocrinology 2021;12.

Wolverine Peptide Therapy (BPC-157 & TB-500)

The Wolverine blend, combining BPC-157 and TB-500, is used to accelerate healing, reduce inflammation, and support tissue repair after injury, surgery, or physical strain.

The Wolverine blend of BPC-157 and TB-500 offers the following potential benefits:

Accelerated healing of tendons, ligaments, and muscle

Improved recovery after surgery or injury

Reduced inflammation and joint pain

Improved mobility and flexibility

Support for gut health

Improved resilience with physical stress and strain

Results often appear in 1-4 weeks, with full benefits typically seen at 4-8 weeks

Safety and Side Effects

When used under medical supervision, the Wolverine blend is generally well-tolerated with a strong safety profile in published studies. Possible side effects include: - injection-site reactions, - headache, - nausea, - fatigue — typically mild and resolving quickly.

​

​

How Does Wolverine Work?

The Wolverine blend combines BPC-157 and TB-500 to enhance the body’s healing and recovery processes through complementary mechanisms.

BPC-157 (Body Protection Compound-157):

TB-500 (Thymosin Beta-4 Acetate):

Wolverine Blend (BPC-157 & TB-500):

Contraindications include pregnancy or breastfeeding, active or suspected cancer, and severe liver or kidney disease. All peptides are sourced from licensed compounding pharmacies.

Disclaimer: The Wolverine peptide blend is not an FDA-approved medication.

References

1. Vasireddi, N., Hahamyan, H., et al. "Emerging use of BPC-157 in orthopaedic sports medicine: A systematic review." HSS Journal 2025;21(2).

2. Pickart L, Vasquez-Soltero JM, et al. "Regeneration or risk? A narrative review of BPC-157 for musculoskeletal healing." Current Reviews in Musculoskeletal Medicine 2025;18(12):611–619.

3. Seiwerth, S., Milavic, M., et al. "Stable gastric pentadecapeptide BPC 157 and wound healing." Frontiers in Pharmacology 2021;12.

4. Malinda, K. M., Wang, J., et al. "Thymosin beta-4 accelerates wound healing." Journal of Investigative Dermatology 1999;113(3):364–368.

5. Xing, Y., Ye, Y., et al. "Progress on the function and application of Thymosin β4." Frontiers in Endocrinology 2021;12.

When used under medical supervision, the Wolverine blend is generally well-tolerated with a strong safety profile in published studies.
Possible side effects include:
- injection-site reactions,
- headache,
- nausea,
- fatigue — typically mild and resolving quickly.

Contraindications include pregnancy or breastfeeding, active or suspected cancer, and severe liver or kidney disease.

All peptides are sourced from licensed compounding pharmacies.